Bioinvest.com

Visit bioinvest.com
  • 9 months ago

    Last scanned

  • 26 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Bioinvest.com

Visit bioinvest.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

Home Page » BioInvest

For more than 30 years, the MTSL (Medical Technology Stock Letter), published by BioInvest, has provided independent investment advice based on rigorous analysis of emerging biotechnology companies and a unique perspective on industry fundamentals. MTSL has a proven track record of identifying many of today’s industry leaders well before the consensus of other analysts.

Bioinvest.com thumbnail
Bioinvest.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Unified Layer, which reserves the following IP addresses for bioinvest.com: 162.241.224.128. Moreover, DNS used with this website include ns1.bluehost.com, ns2.bluehost.com. Subnet identifier ranges from 162.240.0.0 to 162.241.255.255. Classless Inter-Domain Routing (CIDR) is 162.240.0.0/15. ARIN net type is Direct Allocation.

  • 9 months ago

    Last scanned

  • 26 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

Domain & Keywords

The registrar of bioinvest.com is Network Solutions, LLC and the name expires on 2026-10-21. According to open source data, you can reach the owner at mtsl@bioinvest.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.

  • investing
  • research
  • pharmaceutical
  • analysis
  • stocks
  • investments
  • biotech
  • bioinvest
  • MTSL
  • john mccamant biotech

Websites similar to bioinvest.com